GC
EVAR

Globeflex Capital’s Lombard Medical, Inc. EVAR Stock Holding History

Globeflex Capital’s Portfolio EVAR Stock Details EVAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-326
Closed – – 579
2016
Q3 		$0 Hold
326
– – ﹤0.01% 590
2016
Q2 		$0 Buy
+326
New +$453 ﹤0.01% 568

Other funds holding EVAR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Globeflex Capital's EVAR Position: Q4 2016 in Review

Globeflex Capital sold out of Lombard Medical, Inc. (EVAR) in Q4 2016, closing a stake of 326 shares.

Globeflex Capital first reported a position in EVAR in Q2 2016 and held it in 2 quarters. The position peaked at $0 in Q3 2016. 9 funds tracked by Wall St. Rank hold EVAR as of Q4 2016.

  • Globeflex Capital reported no remaining Lombard Medical, Inc. position as of Q4 2016 after selling out during the quarter.
  • Globeflex Capital sold 326 Lombard Medical, Inc. shares in Q4 2016.
  • Globeflex Capital first reported a position in Lombard Medical, Inc. in Q2 2016 and held it in 2 quarters.
  • Globeflex Capital's Lombard Medical, Inc. position peaked at $0 in Q3 2016.
  • 9 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2016.

Based on Globeflex Capital's 13F filing for Q4 2016, filed 13 Feb 2017.